SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 81 filers reported holding SYNTA PHARMACEUTICALS CORP in Q1 2014. The put-call ratio across all filers is 2.65 and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $5,926,000 | -81.9% | 16,932 | -9.9% | 0.00% | – |
Q3 2015 | $32,691,000 | +93.9% | 18,788 | +148.5% | 0.00% | – |
Q2 2015 | $16,859,000 | +455.3% | 7,560 | +383.1% | 0.00% | – |
Q1 2015 | $3,036,000 | -75.7% | 1,565 | -62.2% | 0.00% | – |
Q3 2014 | $12,470,000 | +778.8% | 4,143 | +1093.9% | 0.00% | – |
Q2 2014 | $1,419,000 | -48.5% | 347 | -34.0% | 0.00% | – |
Q4 2013 | $2,756,000 | -96.0% | 526 | -95.2% | 0.00% | – |
Q3 2013 | $69,259,000 | -8.1% | 10,976 | -27.4% | 0.00% | – |
Q2 2013 | $75,404,000 | – | 15,111 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 37,069,140 | $64,500,000 | 87.00% |
ARMISTICE CAPITAL, LLC | 2,000,000 | $3,480,000 | 1.19% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 432,259 | $752,000 | 0.28% |
Geller Advisors LLC | 187,323 | $326,000 | 0.21% |
CAXTON CORP | 57,000 | $99,000 | 0.13% |
Verity Asset Management, Inc. | 64,476 | $112,000 | 0.11% |
TFS CAPITAL LLC | 367,364 | $639,000 | 0.06% |
Cutler Capital Management, LLC | 72,500 | $126,000 | 0.06% |
LUCAS CAPITAL MANAGEMENT | 21,100 | $37,000 | 0.02% |
Nine Chapters Capital Management LLC | 129,700 | $226,000 | 0.02% |